Page last updated: 2024-08-21

azomycin and Cardiomyopathy, Chagas

azomycin has been researched along with Cardiomyopathy, Chagas in 95 studies

Research

Studies (95)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (6.32)	18.7374
1990's	11 (11.58)	18.2507
2000's	23 (24.21)	29.6817
2010's	43 (45.26)	24.3611
2020's	12 (12.63)	2.80

Authors

Authors	Studies
Barbosa, C; Carrillo, I; Castillo, C; Díaz-Araya, G; Fuentes-Retamal, S; González-Herrera, F; Guzmán-Rivera, D; Kemmerling, U; Machado, FS; Maya, JD; Quintero, H; Rabelo, RAN; Rates, M	1
Cevey, ÁC; Goren, NB; Mascolo, PD; Mirkin, GA; Penas, FN; Pieralisi, AV; Sequeyra, AS	1
La Hoz, RM	1
Beccacece, A; Carrara, S; Comandini, UV; Corpolongo, A; Del Nonno, F; Giancola, ML; Maffongelli, G; Mariano, A; Montalbano, M; Nicastri, E; Petrone, A	1
Altcheh, J; Ballering, G; Bochoeyer, A; Chatelain, E; Falk, N; Freilij, H; Garcia Bournissen, F; Goldsman, A; González, NL; Grippo, M; Jurado, L; Moroni, S; Moscatelli, G	1
Almeida, IC; Begum, K; Cardenas-Ovando, RA; Fernández-Figueroa, EA; Iandra da Silva Ferreira, B; Lannes-Vieira, J; Moreira, OC; Pereira, IR; Roy, S; Silva Grijó Farani, P; Vilar-Pereira, G	1
Chastain, DB; Ferraz, C; Franco-Paredes, C; Henao-Martínez, AF; Higuita, NIA; Olivo-Freites, C; Rassi, A; Tuells, J; Villalpando-Carrión, S; Woc-Colburn, L	1
Egui, A; López, MC; Pérez-Antón, E; Segovia, M; Simón, M; Thomas, MC	1
Caldas, IS; Diniz, LF; Gonçalves, RV; Gonçalves-Santos, E; González-Lozano, KJ; Mendonça, AAS; Novaes, RD; Souza-Silva, TG	1
Corral, RS; Hernández, M; Pérez Caballero, E; Santamaría, MH; Wicz, S	1
Gonzalez Garay, AG; Martinez Garcia, M; Reyes, PP; Vallejo, M	1
Arias, E; Bizai, ML; Bottasso, O; Fabbro, D; Olivera, LV; Suasnábar, S	1
Cevey, ÁC; Donato, M; Gelpi, RJ; Goren, NB; Mirkin, GA; Penas, FN; Rada, MJ	1
Batista, R; Loebe, M; Macias, AE; Magarakis, M; Reis, V; Salerno, TA; Tompkins, BA	1
Bahia, MT; Caldas, IS; Caldas, S; Diniz, LF; Menezes, APJ; Nascimento, ÁFDSD; Novaes, RD	1
Echeverria, LE; Morillo, CA	1
Couceiro, KDN; Doria, SS; Ferreira, JMBB; Guerra, JAO; Guerra, MDGVB; Lira, EDF; Ortiz, JV; Pereira, BVM; Silva, MRHDSE; Silva, PRLD	1
Gonçalves, RV; Maldonado, IRSC; Mendonça, AAS; Natali, AJ; Novaes, RD; Souza-Silva, TG; Talvani, A	1
Inga, LAC; Olivera, MJ	1
Coura, JR; de Macedo, RC; Ferreira, AG; Junqueira, AC; Pinto, AY; Santos, LC; Valente, SA; Valente, Vda C	1
Fox, MC; Katz, JT; Lakdawala, N; Sircar, M; Vaidya, A	1
Alarcón de Noya, B; Araujo-Jorge, T; Gascon, J; Grijalva, MJ; Guhl, F; López, MC; Ramsey, JM; Ribeiro, I; Schijman, AG; Sosa-Estani, S; Torrico, F; Viotti, R	1
Bahia, MT; Caldas, IS; Daliry, A; de Carvalho, AC; de Figueiredo Diniz, L; Talvani, A; Torres, RM	1
Bhattacharyya, T; Burleigh, BA; Costales, JA; Garcia-Perez, J; Kotton, CN; Llewellyn, MS; Messenger, LA; Zurita-Leal, AC	1
Maguire, JH	1
Avezum, A; Bonilla, L; Bonilla, R; Britto, C; Connolly, SJ; Guhl, F; Lazdins, J; Marin-Neto, JA; Mattos, A; Meeks, B; Morillo, CA; Pogue, J; Quiroz, R; Rao-Melacini, P; Rassi, A; Rosas, F; Sosa-Estani, S; Velazquez, E; Villena, E; Yusuf, S	1
de Paula Costa, G; Horta, AL; Leite, AL; Natali, AJ; Neves, CA; Penitente, AR; Shrestha, D; Talvani, A	1
Avezum, Á; Cordeiro Mattos, AJ; Oliveira, GB	1
Friedman, JM; Garg, NJ; Lora, JN; Machado, FS; Moraes, DN; Nagajyothi, J; Nunes, MC; Ribeiro, AL; Spray, DC; Tanowitz, HB; Weiss, OS	1
Komajda, M; Ruschitzka, F	1
Avezum, A; Marin-Neto, JA; Morillo, CA	1
Goorhuis, A; Hamers, RL; van Gool, T	1
Cordeiro, MA	1
Gascon, J; Ribeiro, I; Urbina, JA	1
Cevey, ÁC; Goren, NB; Mirkin, GA; Penas, FN	1
Alonso, C; Carrilero, B; Egui, A; Fernandez-Villegas, A; Lasso, P; López, MC; Murcia, L; Segovia, M; Thomas, MC	1
Bierrenbach, AL; Cardoso, CS; Cunha-Neto, E; de Oliveira, LC; Ferreira, AM; Ferreira, JE; Haikal, DS; Oliveira, CD; Reingold, AL; Ribeiro, AL; Sabino, EC	1
Colantonio, LD; Prado, N; Segura, EL; Sosa-Estani, S	1
Bahia, MT; Caldas, S; Gonçalves, KR; Lima, WG; Mazzeti, AL; Santos, FM; Torres, RM	1
Briceno, L; Mosca, W	1
Pays, JF	2
Antunes, AF; Barbosa, Md; Ferreira, JM; Guerra, JA; Maduro, SG; Pereira, BV	1
Cardoso, CS; de Oliveira, LC; Ferreira, AM; Haikal, DS; Oliveira, CD; Ribeiro, AL; Sabino, EC	1
Castillo, C; Cramer, A; González-Herrera, F; Kemmerling, U; Liempi, A; Machado, FS; Maya, JD; Pimentel, P	1
Marin, JA; Rassi, A	1
Avezum, A; Connolly, SJ; Marin-Neto, JA; Morillo, CA; Rassi, A; Rosas, F; Sosa-Estani, S; Yusuf, S	1
Elói-Santos, SM; Faria, AM; Gontijo, ED; Martins-Filho, OA; Pinto Dias, JC; Sathler-Avelar, R; Teixeira-Carvalho, A; Vitelli-Avelar, DM	1
Altcheh, J; Della Védova, CO; Garcia-Bournissen, F; Giglio, N; Koren, G; Mastrantonio, G	1
Branco, JN; Buffolo, E; Gaia, DF; Guilhen, JC; Palma, JH; Teles, A; Teles, CA	1
Avezum, A; Marin-Neto, JA; Mattos, AC; Morillo, CA; Rassi, A; Sosa-Estani, S; Yusuf, S	1
Andrade, SG; Portella, RS	1
Bendhack, LM; da Silva, GK; da Silva, RS; Do Valle Matta, MA; Franco, DW; Guedes, PM; Gutierrez, FR; Oliveira, FS; Rodrigues, GJ; Silva, JS; Zamboni, DS	1
Albajar-Viñas, P; Bahia, MT; Coura, JR; Dias, JC; Lana, Md; Lopes, LA; Machado-de-Assis, GF; Martins, HR; Martins-Filho, OA; Montoya, RA; Wendling, AP	1
Araújo-Jorge, TC; Calvet, CM; de Castro, SL; Molina, JT; Olivieri, BP; Pereira, MC; Urbina, JA	1
Condon, D; Dhiman, M; Garg, NJ; Guan, Z; Gupta, S; Lui, C; Wen, JJ	1
Bocchi, EA; Issa, VS	1
Ferreira, J; Kemmerling, U; López-Muñoz, R; Maya, JD; Morello, A; Orellana, M	1
Bern, C	1
Buysschaert, I; De Keyser, J; Dujardin, K	1
Bahia, MT; Gravel, AS; Lima, WG; Martins, TA; Santos, FM; Talvani, A; Torres, RM	1
Ballesteros, LA; Basile, L; Rodrigo, C; Roure, S; Sabrià, M; Valerio-Sallent, L	1
Britto, C; Guhl, F; Lima-Ferreira, C; Marin-Neto, JA; Melo, MF; Moreira, OC; Morillo, CA; Ramírez, JD; Sosa-Estani, S; Velázquez, E	1
Gallerano, RR; Sosa, RR	1
Campos-de-Carvalho, AC; Garcia, S; Ramos, CO; Ribeiro-Dos-Santos, R; Rodrigues, MM; Senra, JF; Soares, MB; Vilas-Boas, F	1
Basombrío, MA; Cardozo, R; Corrales, M; Segura, MA; Urbina, JA	1
Colmenarez-Mendoza, HJ; Dávila-Spinetti, DF; Lobo-Vielma, L	1
Alvarez, MG; Armenti, A; Bertocchi, G; Lococo, B; Petti, M; Vigliano, C; Viotti, R	1
Reyes, PA; Vallejo, M	1
Alvarez, MG; Armenti, A; Bertocchi, G; Lococo, B; Petti, M; Postan, M; Vigliano, C; Viotti, R	1
Braz, LM; Gakiya, E; Ibrahim, KY; Lopes, MH; Nunes Westphalen, EV; Oliveira, OC; Sartori, AM; Shikanai-Yasuda, MA	1
Cunha-Neto, E; Maciel, BC; Marin-Neto, JA; Simões, MV	1
Bustamante, JM; Enders, JE; Fernández, AR; Fretes, RE; Paglini-Oliva, P; Presti, MS; Rivarola, HW	1
Albajar-Viñas, P; Gimena, B; González-Mediero, G; Martínez-Vázquez, C; Román, F; Sopeña, B; Sousa, J	1
Bahk, TJ; Daniels, MD; Engman, DM; Giafis, N; Hyland, KV; Leon, JS; Wang, K; Woods, LM	1
Castro-E-Silva, O; Figueiredo, JF; Gaspar, GG; Maciel, BC; Marin Neto, JA; Martinelli, AL; Melo, L; Passos, AD; Romano, MM; Rossi, MA; Sankarankutty, AK; Souza, FF; Teixeira, AC	1
Cabeza Meckert, P; Chambó, JG; Gelpi, R; Laguens, RP	1
Conroy, J; Cuckler, AC; Malanga, CM	1
Marin-Neto, JA; Simões, MV; Soares, FA	1
Bellotti, G; Bocchi, EA; de Lourdes Higuchi, M; Fiorelli, A; Jatene, A; Kalil, J; Pilleggi, F; Stolf, N; Uip, D	1
Bestetti, RB	2
Añez, N; Carrasco, HA; Fuenmayor, C; Inglessis, I; Parada, H	1
Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML	1
Rassi Júnior, A; Rassi, A	1
Giovannoni, AG; Montero, A	1
Córdoba, JC; Solórzano, E; Souto Maior, I; Teixeira, AR	1
Cunha Neto, E; Rizzo, LV; Silva, R; Teixeira, AR	1
Cunha Neto, E; Rizzo, LV; Santana, JM; Silva, R; Teixeira, AR	1
Andrade, SG; Freitas, LA; Santiago, CM; Silva, RC	1
de Arruda Júnior, ER	1
Apt, W; Arab, F; Arribada, A; Luksic, I; Solé, C; Ugarte, JM	1
Gallerano, RH; Meirovich, CI; Montrull, HL; Sosa, RR	1

Reviews

12 review(s) available for azomycin and Cardiomyopathy, Chagas

Article	Year
Transplantation for chagas' disease: closing the knowledge gap. Current opinion in infectious diseases, 2022, 10-01, Volume: 35, Issue:5 Topics: Chagas Cardiomyopathy; Chagas Disease; Clinical Trials, Phase II as Topic; Humans; Nitroimidazoles; Randomized Controlled Trials as Topic; Tissue Donors; Transplant Recipients; Trypanocidal Agents; Trypanosoma cruzi	2022
Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection). The Cochrane database of systematic reviews, 2020, 12-11, Volume: 12 Topics: Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Humans; Nifurtimox; Nitroimidazoles; Parasitemia; Placebos; Randomized Controlled Trials as Topic; Trypanocidal Agents; Trypanosoma cruzi	2020
Cardiac surgery for Chagas disease. Journal of cardiac surgery, 2018, Volume: 33, Issue:10 Topics: Cardiac Surgical Procedures; Chagas Cardiomyopathy; Echocardiography; Female; Heart Aneurysm; Heart Ventricles; Humans; Magnetic Resonance Imaging; Middle Aged; Nifurtimox; Nitroimidazoles; Serologic Tests; Stroke Volume; Treatment Outcome; Trypanocidal Agents	2018
American Trypanosomiasis (Chagas Disease). Infectious disease clinics of North America, 2019, Volume: 33, Issue:1 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Clinical Trials as Topic; Disease Progression; Disease Vectors; Humans; Nitroimidazoles; Triatominae; Trypanocidal Agents; Trypanosoma cruzi	2019
Developments in the management of Chagas cardiomyopathy. Expert review of cardiovascular therapy, 2015, Volume: 13, Issue:12 Topics: Animals; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Chagas Disease; Disease Management; Electrocardiography; Heart Failure; Humans; Nanotechnology; Nitroimidazoles; Stem Cell Transplantation; Trypanocidal Agents; Vaccines	2015
[What is not searched, it is difficult to find: Chagas' disease]. Giornale italiano di cardiologia (2006), 2016, Volume: 17, Issue:5 Topics: Chagas Cardiomyopathy; Chagas Disease; Emigrants and Immigrants; Humans; Italy; Neglected Diseases; Nifurtimox; Nitroimidazoles; Prevalence; South America; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi	2016
Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina. Paediatric drugs, 2009, Volume: 11, Issue:1 Topics: Argentina; Chagas Cardiomyopathy; Chagas Disease; Child; Drug Administration Schedule; Humans; Nifurtimox; Nitroimidazoles; Trypanocidal Agents	2009
Chagas disease: Present status of pathogenic mechanisms and chemotherapy. Biological research, 2010, Volume: 43, Issue:3 Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Cyclooxygenase 1; Cyclooxygenase 2; Humans; Mice; Nifurtimox; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi	2010
Antitrypanosomal therapy for chronic Chagas' disease. The New England journal of medicine, 2011, Jun-30, Volume: 364, Issue:26 Topics: Adult; Animals; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Progression; Electrocardiography; Female; Humans; Life Cycle Stages; Nifurtimox; Nitroimidazoles; Practice Guidelines as Topic; Trypanocidal Agents; Trypanosoma cruzi	2011
Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection). The Cochrane database of systematic reviews, 2005, Oct-19, Issue:4 Topics: Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Clinical Trials as Topic; Humans; Imidazoles; Nifurtimox; Nitroimidazoles; Trypanocidal Agents	2005
Pathogenesis of chronic Chagas heart disease. Circulation, 2007, Mar-06, Volume: 115, Issue:9 Topics: Animals; Antibodies, Protozoan; Autoimmunity; Autonomic Nervous System; Chagas Cardiomyopathy; Cricetinae; Death, Sudden, Cardiac; Denervation; Heart; Heart Conduction System; Host-Parasite Interactions; Humans; Mice; Microcirculation; Models, Animal; Models, Cardiovascular; Models, Neurological; Molecular Mimicry; Myocardial Ischemia; Myocarditis; Myocardium; Nitroimidazoles; Parasympathetic Nervous System; T-Lymphocyte Subsets; Trypanocidal Agents; Trypanosoma cruzi; Vaccination; Ventricular Dysfunction, Left	2007
[Human American trypanosomiasis 90 years after its discovery by Carlos Chagas. II--Clinical aspects, physiopathology, diagnosis and treatment]. Medecine tropicale : revue du Corps de sante colonial, 1999, Volume: 59, Issue:1 Topics: Brain Diseases; Chagas Cardiomyopathy; Chagas Disease; Child; Child, Preschool; Diagnosis, Differential; Disease Vectors; Double-Blind Method; Follow-Up Studies; Gastrointestinal Diseases; Humans; Immunization; Immunologic Deficiency Syndromes; Longitudinal Studies; Myocarditis; Nitroimidazoles; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Trypanocidal Agents; Vaccines	1999

Trials

6 trial(s) available for azomycin and Cardiomyopathy, Chagas

Article	Year
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. The New England journal of medicine, 2015, Volume: 373, Issue:14 Topics: Adult; Aged; Cardiovascular Diseases; Chagas Cardiomyopathy; Chronic Disease; Disease Progression; Female; Genotype; Humans; Male; Middle Aged; Nitroimidazoles; Parasite Load; Polymerase Chain Reaction; Proportional Hazards Models; Prospective Studies; Treatment Failure; Trypanocidal Agents; Trypanosoma cruzi	2015
Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:5 Topics: Adolescent; Argentina; Chagas Cardiomyopathy; Child; Cohort Studies; Double-Blind Method; Electrocardiography; Female; Humans; Male; Nitroimidazoles; Retrospective Studies; Trypanocidal Agents; Trypanosoma cruzi	2016
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). American heart journal, 2008, Volume: 156, Issue:1 Topics: Chagas Cardiomyopathy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Latin America; Male; Nitroimidazoles; Pilot Projects; Risk Assessment; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome; Trypanosomiasis	2008
Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Annals of internal medicine, 2006, May-16, Volume: 144, Issue:10 Topics: Adult; Animals; Antibodies, Protozoan; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Prognosis; Sensitivity and Specificity; Trypanocidal Agents; Trypanosoma cruzi	2006
Clinical trial of benznidazole and an immunopotentiator against Chagas disease in Chile. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986, Volume: 80, Issue:6 Topics: Anti-Infective Agents; Chagas Cardiomyopathy; Clinical Trials as Topic; Double-Blind Method; Humans; Immunoglobulins; Nitroimidazoles; Trypanocidal Agents	1986
[Allopurinol in the treatment of chronic Chagas' disease]. Arquivos brasileiros de cardiologia, 1985, Volume: 45, Issue:3 Topics: Allopurinol; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Nifurtimox; Nitroimidazoles; Trypanocidal Agents	1985

Other Studies

77 other study(ies) available for azomycin and Cardiomyopathy, Chagas

Article	Year
Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease. PLoS neglected tropical diseases, 2021, Volume: 15, Issue:11 Topics: Animals; Chagas Cardiomyopathy; Chronic Disease; Disease Models, Animal; Docosahexaenoic Acids; Female; Heart; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nitroimidazoles; Parasite Load; Receptors, Formyl Peptide; Trypanosoma cruzi	2021
Benznidazole Anti-Inflammatory Effects in Murine Cardiomyocytes and Macrophages Are Mediated by Class I PI3Kδ. Frontiers in immunology, 2021, Volume: 12 Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Chagas Cardiomyopathy; Chromones; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Female; Humans; Lipopolysaccharides; Macrophages; Male; Mice; Morpholines; Myocytes, Cardiac; Nitroimidazoles; Primary Cell Culture; RAW 264.7 Cells	2021
Severe drug-induced liver injury (DILI) associated with benznidazole therapy for Chagas' disease. The Journal of antimicrobial chemotherapy, 2022, 11-28, Volume: 77, Issue:12 Topics: Chagas Cardiomyopathy; Chagas Disease; Chemical and Drug Induced Liver Injury; Humans; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi	2022
Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study. PLoS neglected tropical diseases, 2022, Volume: 16, Issue:12 Topics: Adult; Cardiology; Chagas Cardiomyopathy; Chagas Disease; Child; Humans; Nifurtimox; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi	2022
Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy. PLoS neglected tropical diseases, 2023, Volume: 17, Issue:3 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Fibrosis; Gene Expression Profiling; Mice; MicroRNAs; Nitroimidazoles; Pentoxifylline; Transcriptome; Trypanocidal Agents; Trypanosoma cruzi	2023
Clinical Characteristics and Outcomes of Chagas Disease in the United States: A Multicenter Retrospective Analysis. The American journal of tropical medicine and hygiene, 2023, 11-01, Volume: 109, Issue:5 Topics: Chagas Cardiomyopathy; Chagas Disease; Humans; Immunoglobulin G; Nitroimidazoles; Retrospective Studies; Trypanosoma cruzi; United States	2023
Immunological exhaustion and functional profile of CD8 Acta tropica, 2020, Volume: 202 Topics: Biomarkers; CD8-Positive T-Lymphocytes; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Costimulatory and Inhibitory T-Cell Receptors; Cytokines; Humans; Nitroimidazoles; Programmed Cell Death 1 Receptor; Signaling Lymphocytic Activation Molecule Family; Trypanocidal Agents; Trypanosoma cruzi	2020
Could phenothiazine-benznidazole combined chemotherapy be effective in controlling heart parasitism and acute infectious myocarditis? Pharmacological research, 2020, Volume: 158 Topics: Animals; Antiprotozoal Agents; Chagas Cardiomyopathy; Chagas Disease; Drug Therapy, Combination; Female; Mice; Myocarditis; Nitroimidazoles; Phenothiazines; Trypanocidal Agents; Trypanosoma cruzi	2020
Dual chemotherapy with benznidazole at suboptimal dose plus curcumin nanoparticles mitigates Trypanosoma cruzi-elicited chronic cardiomyopathy. Parasitology international, 2021, Volume: 81 Topics: Animals; Chagas Cardiomyopathy; Chronic Disease; Curcumin; Female; Male; Mice; Mice, Inbred C57BL; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi	2021
Trypanocidal therapy among children infected by Trypanosoma cruzi. Serological and electrocardiographic changes over a mean twenty-five-years follow-up period. Acta tropica, 2021, Volume: 222 Topics: Adolescent; Chagas Cardiomyopathy; Chagas Disease; Child; Follow-Up Studies; Humans; Nifurtimox; Nitroimidazoles; Retrospective Studies; Trypanocidal Agents; Trypanosoma cruzi	2021
Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease. International journal for parasitology. Drugs and drug resistance, 2017, Volume: 7, Issue:3 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Diastole; Fenofibrate; Fibrosis; Humans; Inflammation; Interleukin-6; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Nitroimidazoles; PPAR alpha; Stroke Volume; Trypanocidal Agents; Trypanosoma cruzi; Tumor Necrosis Factor-alpha; Ventricular Dysfunction; Ventricular Function	2017
Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs. Acta tropica, 2019, Volume: 189 Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Chronic Disease; Collagen Type III; Disease Models, Animal; Disease Progression; DNA, Protozoan; Dogs; Drug Resistance; Fibrosis; Heart; Myocardium; Nitroimidazoles; Parasite Load; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi	2019
Cardiac Evaluation in the Acute Phase of Chagas' Disease with Post-Treatment Evolution in Patients Attended in the State of Amazonas, Brazil. Arquivos brasileiros de cardiologia, 2019, Volume: 112, Issue:3 Topics: Adolescent; Adult; Brazil; Chagas Cardiomyopathy; Chagas Disease; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi; Young Adult	2019
Concomitant exercise training attenuates the cardioprotective effects of pharmacological therapy in a murine model of acute infectious myocarditis. Life sciences, 2019, Aug-01, Volume: 230 Topics: Animals; Antioxidants; Cardiotonic Agents; Catalase; Chagas Cardiomyopathy; Chagas Disease; Cytokines; Disease Models, Animal; Heart; Inflammation; Interleukin-10; Male; Myocarditis; Myocardium; Nitric Oxide; Nitroimidazoles; Parasitemia; Physical Conditioning, Animal; Rats; Rats, Wistar; Superoxide Dismutase; Trypanosoma cruzi; Tumor Necrosis Factor-alpha	2019
Reactivation of Chagas disease in a heart transplant patient infected by sylvatic Trypanosoma cruzi discrete typing unit I. Revista da Sociedade Brasileira de Medicina Tropical, 2019, Jul-18, Volume: 52 Topics: Chagas Cardiomyopathy; DNA, Protozoan; Genetic Variation; Genotype; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Nitroimidazoles; Polymerase Chain Reaction; Trypanocidal Agents	2019
Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease. PloS one, 2013, Volume: 8, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Antibodies, Protozoan; Brazil; Chagas Cardiomyopathy; Chagas Disease; Child; Child, Preschool; Disease Progression; Follow-Up Studies; Humans; Immunoglobulin G; Middle Aged; Nitroimidazoles; Topography, Medical; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi; Young Adult	2013
Interactive medical case. A patient with syncope. The New England journal of medicine, 2013, Aug-15, Volume: 369, Issue:7 Topics: Adult; Antibodies, Protozoan; Bundle-Branch Block; Chagas Cardiomyopathy; Defibrillators, Implantable; Diagnosis, Differential; Echocardiography; Electrocardiography; Humans; Immunoglobulin G; Male; Nitroimidazoles; Positron-Emission Tomography; Stroke Volume; Syncope; Tachycardia, Ventricular; Trypanocidal Agents; Trypanosoma cruzi	2013
Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Antibodies, Protozoan; Chagas Cardiomyopathy; Child; Chronic Disease; Disease Management; Drug Administration Schedule; Humans; Nifurtimox; Nitroimidazoles; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi	2014
Anti-adrenergic and muscarinic receptor autoantibodies in a canine model of Chagas disease and their modulation by benznidazole. International journal of cardiology, 2014, Jan-01, Volume: 170, Issue:3 Topics: Animals; Autoantibodies; Chagas Cardiomyopathy; Disease Models, Animal; Dogs; Humans; Immunosuppressive Agents; Nitroimidazoles; Receptor, Muscarinic M2; Receptors, Adrenergic, beta	2014
Chagas disease reactivation in a heart transplant patient infected by domestic Trypanosoma cruzi discrete typing unit I (TcIDOM). Parasites & vectors, 2015, Aug-25, Volume: 8 Topics: Adult; Chagas Cardiomyopathy; DNA, Protozoan; Heart Transplantation; Humans; Male; Nifurtimox; Nitroimidazoles; Phylogeny; Recurrence; Trypanocidal Agents; Trypanosoma cruzi	2015
Treatment of Chagas' Disease--Time Is Running Out. The New England journal of medicine, 2015, Volume: 373, Issue:14 Topics: Chagas Cardiomyopathy; Female; Humans; Male; Nitroimidazoles; Trypanocidal Agents	2015
Enalapril in Combination with Benznidazole Reduces Cardiac Inflammation and Creatine Kinases in Mice Chronically Infected with Trypanosoma cruzi. The American journal of tropical medicine and hygiene, 2015, Volume: 93, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chagas Cardiomyopathy; Enalapril; Inflammation; Male; Mice; Mice, Inbred C57BL; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi	2015
Perspectives in Chagas disease treatment. Global heart, 2015, Volume: 10, Issue:3 Topics: Animals; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Chagas Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Disease Management; Heart Failure; Humans; Insect Control; Insect Vectors; Nifurtimox; Nitroimidazoles; Thromboembolism; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi	2015
The year in cardiology 2015: heart failure. European heart journal, 2016, Feb-01, Volume: 37, Issue:5 Topics: Alcohol Drinking; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Chagas Cardiomyopathy; Chronic Disease; Diabetes Mellitus, Type 2; Genetic Therapy; Heart Failure; Humans; Hypoglycemic Agents; Nitroimidazoles; Respiration, Artificial; Risk Factors; Sleep Apnea, Central; Trypanocidal Agents	2016
Benznidazole for Chronic Chagas' Cardiomyopathy. The New England journal of medicine, 2016, 01-14, Volume: 374, Issue:2 Topics: Chagas Cardiomyopathy; Female; Humans; Male; Nitroimidazoles; Trypanocidal Agents	2016
Benznidazole for Chronic Chagas' Cardiomyopathy. The New England journal of medicine, 2016, 01-14, Volume: 374, Issue:2 Topics: Chagas Cardiomyopathy; Female; Humans; Male; Nitroimidazoles; Trypanocidal Agents	2016
Benznidazole for Chronic Chagas' Cardiomyopathy. The New England journal of medicine, 2016, 01-14, Volume: 374, Issue:2 Topics: Chagas Cardiomyopathy; Female; Humans; Male; Nitroimidazoles; Trypanocidal Agents	2016
Benznidazole for Chronic Chagas' Cardiomyopathy. The New England journal of medicine, 2016, 01-14, Volume: 374, Issue:2 Topics: Chagas Cardiomyopathy; Female; Humans; Male; Nitroimidazoles; Trypanocidal Agents	2016
Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain. International journal for parasitology. Drugs and drug resistance, 2016, Volume: 6, Issue:1 Topics: Animals; Cells, Cultured; Chagas Cardiomyopathy; Chagas Disease; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Heart; Humans; Immunologic Factors; Inflammation; Interleukin-6; Mice; Mice, Inbred BALB C; Myocytes, Cardiac; NF-kappa B; Nitric Oxide Synthase Type II; Nitroimidazoles; Parasite Load; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi; Tumor Necrosis Factor-alpha	2016
A 12-mer repetitive antigenic epitope from Trypanosoma cruzi is a potential marker of therapeutic efficacy in chronic Chagas' disease. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:7 Topics: Adult; Antigens, Protozoan; Antiprotozoal Agents; Biomarkers; C-Reactive Protein; Chagas Cardiomyopathy; Drug Monitoring; Epitopes; Humans; Interleukin-6; Nitroimidazoles; Therapeutics; Trypanosoma cruzi	2016
Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile. BMJ open, 2016, 05-04, Volume: 6, Issue:5 Topics: Aged; Biomarkers; Brazil; Chagas Cardiomyopathy; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Heart Failure; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroimidazoles; Peptide Fragments; Population Surveillance; Predictive Value of Tests; Prognosis; Prospective Studies; Quality of Life; Socioeconomic Factors	2016
Chagas cardiomyopathy: The potential effect of benznidazole treatment on diastolic dysfunction and cardiac damage in dogs chronically infected with Trypanosoma cruzi. Acta tropica, 2016, Volume: 161 Topics: Animals; Chagas Cardiomyopathy; Dogs; Female; Heart; Humans; Male; Models, Animal; Myocardium; Nitroimidazoles; Parasite Load; Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi	2016
[The third and new face of Chagas disease]. Bulletin de la Societe de pathologie exotique (1990), 2016, Volume: 109, Issue:3 Topics: Adult; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Progression; Humans; Neglected Diseases; Nitroimidazoles; Treatment Failure	2016
Chronic Heart Disease after Treatment of Oral Acute Chagas Disease. Arquivos brasileiros de cardiologia, 2016, Volume: 107, Issue:2 Topics: Acute Disease; Adolescent; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Chagas Disease; Electrocardiography; Humans; Male; Nitroimidazoles; Recurrence; Trypanocidal Agents	2016
Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil. PloS one, 2016, Volume: 11, Issue:11 Topics: Aged; Brazil; Chagas Cardiomyopathy; Chronic Disease; Comorbidity; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nitroimidazoles; Socioeconomic Factors; Trypanocidal Agents	2016
Simvastatin Attenuates Endothelial Activation through 15-Epi-Lipoxin A4 Production in Murine Chronic Chagas Cardiomyopathy. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3 Topics: Animals; Anticholesteremic Agents; Arachidonate 5-Lipoxygenase; Chagas Cardiomyopathy; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; E-Selectin; Endothelium; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Lipoxins; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Myocardium; Nitroimidazoles; Parasitemia; Simvastatin; Survival Analysis; Trypanocidal Agents; Trypanosoma cruzi; Vascular Cell Adhesion Molecule-1	2017
Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial. Memorias do Instituto Oswaldo Cruz, 2017, Volume: 112, Issue:3 Topics: Animals; Chagas Cardiomyopathy; Chronic Disease; Clinical Trials as Topic; Disease Progression; Female; Humans; Latin America; Male; Middle Aged; Nitroimidazoles; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi	2017
Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease. Scandinavian journal of immunology, 2008, Volume: 68, Issue:5 Topics: Adult; Aged; Animals; Antigens, Protozoan; B-Lymphocytes; Chagas Cardiomyopathy; Chagas Disease; Chi-Square Distribution; Cohort Studies; Cytokines; Female; Flow Cytometry; Humans; Immunophenotyping; Leukocytes, Mononuclear; Male; Middle Aged; Nitroimidazoles; T-Lymphocytes; Trypanocidal Agents; Trypanosoma cruzi	2008
Post-transplant lymphoproliferative disease presenting as a mass in the left ventricle in a heart transplant recipient at long-term follow-up. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2009, Volume: 28, Issue:2 Topics: Chagas Cardiomyopathy; Electrocardiography; Fatal Outcome; Follow-Up Studies; Heart Neoplasms; Heart Transplantation; Heart Ventricles; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nitroimidazoles; Postoperative Complications; Recurrence; Time Factors; Ultrasonography	2009
Chagas' disease and its toll on the heart. European heart journal, 2009, Volume: 30, Issue:17 Topics: Acute Disease; Arrhythmias, Cardiac; Brazil; Chagas Cardiomyopathy; Chronic Disease; Defibrillators, Implantable; Heart Failure; History, 20th Century; Humans; Nitroimidazoles; Nobel Prize; Trypanocidal Agents	2009
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Memorias do Instituto Oswaldo Cruz, 2009, Volume: 104 Suppl 1 Topics: Animals; Chagas Cardiomyopathy; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Evidence-Based Medicine; Humans; Nitroimidazoles; Patient Selection; Pilot Projects; Trypanocidal Agents	2009
Trypanosoma cruzi: parasite antigens sequestered in heart interstitial dendritic cells are related to persisting myocarditis in benznidazole-treated mice. Memorias do Instituto Oswaldo Cruz, 2009, Volume: 104, Issue:7 Topics: Animals; Antibodies, Monoclonal; Antigens, Protozoan; Chagas Cardiomyopathy; Dendritic Cells; Disease Models, Animal; Drug Resistance; Mice; Myocarditis; Myocardium; Nitroimidazoles; Time Factors; Trypanocidal Agents; Trypanosoma cruzi	2009
Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease. British journal of pharmacology, 2010, Volume: 160, Issue:2 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Drug Resistance; Drug Synergism; Female; Humans; Macrophages; Mice; Nitric Oxide; Nitric Oxide Donors; Nitroimidazoles; Organometallic Compounds; Parasitemia; Survival Rate; Trypanocidal Agents; Trypanosoma cruzi	2010
Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment. Memorias do Instituto Oswaldo Cruz, 2009, Volume: 104, Issue:8 Topics: Adolescent; Adult; Antibodies, Protozoan; Brazil; Chagas Cardiomyopathy; Chagas Disease; Child; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Male; Nitroimidazoles; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi; Young Adult	2009
A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease. International journal of antimicrobial agents, 2010, Volume: 36, Issue:1 Topics: Animals; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Female; Heart; Humans; Mice; Myocardium; Nitroimidazoles; Survival Analysis; Triazoles; Trypanosoma cruzi	2010
Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats. Journal of the American College of Cardiology, 2010, Jun-01, Volume: 55, Issue:22 Topics: Analysis of Variance; Animals; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Cyclic N-Oxides; Disease Models, Animal; Disease Progression; Heart Function Tests; Hemodynamics; Lipid Peroxidation; Mitochondria, Heart; Nitroimidazoles; Oxidative Stress; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Trypanosoma cruzi	2010
Antitrypanosomal agents: treatment or threat? Lancet (London, England), 2010, Sep-04, Volume: 376, Issue:9743 Topics: Chagas Cardiomyopathy; Chagas Disease; Clinical Trials as Topic; Drug Administration Schedule; Drug Eruptions; Humans; Meta-Analysis as Topic; Nifurtimox; Nitroimidazoles; Polyneuropathies; Trypanocidal Agents; Trypanosoma cruzi; United States	2010
Stone heart or apical retraction and calcification in Chagas' cardiomyopathy. European heart journal. Cardiovascular Imaging, 2012, Volume: 13, Issue:7 Topics: Adult; Barium Sulfate; Chagas Cardiomyopathy; Contrast Media; Coronary Angiography; Diagnosis, Differential; Echocardiography, Transesophageal; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Humans; Magnetic Resonance Imaging; Male; Nitroimidazoles; Polymerase Chain Reaction; Radiography, Thoracic; Trypanocidal Agents	2012
Cardiomyopathy prognosis after benznidazole treatment in chronic canine Chagas' disease. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8 Topics: Animal Experimentation; Animals; Antiprotozoal Agents; Chagas Cardiomyopathy; Chronic Disease; DNA, Protozoan; Dog Diseases; Dogs; Heart; Nitroimidazoles; Parasitemia; Prognosis; Trypanosoma cruzi	2012
[A clinical and epidemiological study of the Trypanosoma cruzi infected population in the north metropolitan area of Barcelona]. Revista clinica espanola, 2012, Volume: 212, Issue:7 Topics: Adult; Asymptomatic Infections; Chagas Cardiomyopathy; Chagas Disease; Emigrants and Immigrants; Female; Humans; Incidence; Male; Nitroimidazoles; Prospective Studies; Spain; Trypanocidal Agents	2012
Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial. Acta tropica, 2013, Volume: 125, Issue:1 Topics: Antiprotozoal Agents; Argentina; Brazil; Chagas Cardiomyopathy; Colombia; DNA, Protozoan; Double-Blind Method; Drug Monitoring; Humans; Molecular Diagnostic Techniques; Nitroimidazoles; Parasite Load; Parasitemia; Parasitology; Placebos; Randomized Controlled Trials as Topic; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Trypanosoma cruzi	2013
[Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy]. Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2000, Volume: 57, Issue:2 Topics: Adolescent; Adult; Aged; Allopurinol; Antiprotozoal Agents; Chagas Cardiomyopathy; Chagas Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nifurtimox; Nitroimidazoles; Prospective Studies; Retrospective Studies; Time Factors; Treatment Outcome; Trypanocidal Agents	2000
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:4 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Heart; Humans; Male; Mice; Mice, Inbred BALB C; Myocarditis; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi	2005
Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:4 Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Ergosterol; Male; Mice; Nitroimidazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi	2005
[Mechanisms responsible for myocardial damage progression in chronic Chagas' disease]. Revista espanola de cardiologia, 2005, Volume: 58, Issue:9 Topics: Allopurinol; Antimetabolites; Chagas Cardiomyopathy; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Electrocardiography; Follow-Up Studies; Humans; Nitroimidazoles; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Trypanocidal Agents	2005
[Clinical predictors of chronic chagasic myocarditis progression]. Revista espanola de cardiologia, 2005, Volume: 58, Issue:9 Topics: Adult; Chagas Cardiomyopathy; Disease Progression; Echocardiography; Electrocardiography; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocarditis; Nitroimidazoles; Prognosis; Proportional Hazards Models; Risk Factors; Time Factors; Trypanocidal Agents	2005
Summaries for patients. Long-term outcomes of treating nonacute Chagas disease with benznidazole. Annals of internal medicine, 2006, May-16, Volume: 144, Issue:10 Topics: Adult; Animals; Antibodies, Protozoan; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Prognosis; Sensitivity and Specificity; Trypanocidal Agents; Trypanosoma cruzi	2006
Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Annals of tropical medicine and parasitology, 2007, Volume: 101, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Brazil; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Female; HIV Infections; Humans; Male; Meningoencephalitis; Middle Aged; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Xenodiagnosis	2007
Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy. International journal of antimicrobial agents, 2007, Volume: 29, Issue:6 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Mice; Nitroimidazoles; Thioridazine; Trypanocidal Agents	2007
[Chest pain and peripheral eosinophilia]. Revista clinica espanola, 2007, Volume: 207, Issue:2 Topics: Adult; Amiodarone; Chagas Cardiomyopathy; Chest Pain; Diuretics; Drug Therapy, Combination; Electrocardiography; Eosinophilia; Furosemide; Humans; Male; Nitroimidazoles; Radiography, Thoracic; Trypanocidal Agents; Vasodilator Agents	2007
Modulation of autoimmunity by treatment of an infectious disease. Infection and immunity, 2007, Volume: 75, Issue:7 Topics: Animals; Autoimmune Diseases; Autoimmunity; Chagas Cardiomyopathy; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Male; Mice; Myocarditis; Myosins; Nitroimidazoles; Treatment Outcome; Trypanosoma cruzi	2007
Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Transplantation proceedings, 2008, Volume: 40, Issue:3 Topics: Adult; Animals; Chagas Cardiomyopathy; Echocardiography; Fatal Outcome; Heart; Humans; Liver Transplantation; Male; Nitroimidazoles; Pancreas Transplantation; Postoperative Complications; Trypanocidal Agents; Trypanosoma cruzi; Ventricular Dysfunction, Left	2008
Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs. Medicina, 1983, Volume: 43, Issue:2 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Female; Intestinal Diseases, Parasitic; Mice; Mice, Inbred Strains; Myositis; Nifurtimox; Nitroimidazoles; Trypanocidal Agents	1983
Therapeutic efficacy of several nitroimidazoles for experimental Trypanosoma cruzi infections in mice. The Journal of parasitology, 1981, Volume: 67, Issue:1 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Drug Evaluation, Preclinical; Male; Mice; Myocarditis; Nitroimidazoles; Structure-Activity Relationship; Trypanosoma cruzi	1981
Severe myocarditis and esophagitis during reversible long standing Chagas' disease recrudescence in immunocompromised host. International journal of cardiology, 1995, Volume: 49, Issue:3 Topics: Adult; Chagas Cardiomyopathy; Esophagitis; Female; Humans; Immunocompromised Host; Nitroimidazoles; Trypanocidal Agents; Ultrasonography	1995
Long-term follow-up after heart transplantation in Chagas' disease. Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 2 Topics: Actuarial Analysis; Adrenal Cortex Hormones; Adult; Azathioprine; Chagas Cardiomyopathy; Chagas Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Male; Necrosis; Nitroimidazoles; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Trypanocidal Agents	1993
Should benznidazole be used in chronic Chagas' disease? Lancet (London, England), 1997, Mar-01, Volume: 349, Issue:9052 Topics: Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Follow-Up Studies; Humans; Neoplasms; Nitroimidazoles; Trypanocidal Agents	1997
Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. International journal of cardiology, 1997, Jun-27, Volume: 60, Issue:1 Topics: Acute Disease; Adolescent; Adult; Animals; Cardiomegaly; Chagas Cardiomyopathy; Child; Child, Preschool; Electrocardiography; Female; Humans; Infant; Male; Middle Aged; Myocardium; Nitroimidazoles; Pericardial Effusion; Trypanocidal Agents; Trypanosoma cruzi; Venezuela	1997
Heart transplantation as a treatment for patients with end-stage Chagas' heart disease. Circulation, 1997, Oct-21, Volume: 96, Issue:8 Topics: Chagas Cardiomyopathy; Heart Transplantation; Humans; Nitroimidazoles; Secondary Prevention; Trypanocidal Agents	1997
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1998, Volume: 17, Issue:4 Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents	1998
[Treatment of chronic Chagas' disease. Is the etiological treatment effective?]. Arquivos brasileiros de cardiologia, 1998, Volume: 71, Issue:4 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Humans; Nitroimidazoles; Treatment Outcome; Trypanocidal Agents	1998
Chagas' disease. Lancet (London, England), 2001, Jul-07, Volume: 358, Issue:9275 Topics: Adolescent; Adult; Chagas Cardiomyopathy; Chagas Disease; Child; Chronic Disease; Humans; Nitroimidazoles; Risk Factors; Trypanocidal Agents	2001
Chagas' disease: lymphoma growth in rabbits treated with Benznidazole. The American journal of tropical medicine and hygiene, 1990, Volume: 43, Issue:2 Topics: Animals; Antibodies, Protozoan; Chagas Cardiomyopathy; Chagas Disease; Female; Hypersensitivity, Delayed; Immunity, Cellular; Intradermal Tests; Liver; Lymphoma, Non-Hodgkin; Male; Molecular Structure; Myocardium; Nitroimidazoles; Rabbits; Trypanocidal Agents; Trypanosoma cruzi	1990
Trypanocidal nitroarene treatment of experimental Trypanosoma cruzi infection does not prevent progression of chronic-phase heart lesions in rabbits. The Journal of infectious diseases, 1990, Volume: 162, Issue:6 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Nifurtimox; Nitroimidazoles; Rabbits; Trypanocidal Agents	1990
Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes. Journal of comparative pathology, 1990, Volume: 103, Issue:1 Topics: Animals; Chagas Cardiomyopathy; Female; Injections, Intraperitoneal; Lymphoma, Non-Hodgkin; Male; Myocarditis; Myositis; Nifurtimox; Nitrofurans; Nitroimidazoles; Rabbits; Trypanosoma cruzi	1990
Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study. Bulletin of the World Health Organization, 1987, Volume: 65, Issue:5 Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Female; Male; Mice; Myocardium; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi	1987
[Tolerance to benzonidazole during the etiological treatment of Chagas' disease]. Arquivos brasileiros de cardiologia, 1987, Volume: 48, Issue:6 Topics: Adult; Animals; Body Weight; Chagas Cardiomyopathy; Chagas Disease; Drug Tolerance; Female; Humans; Male; Middle Aged; Nitroimidazoles; Trypanosoma cruzi	1987